Eli Lilly: 1 Big Reason for UK Gateway Lab Reconsideration
Reports suggest pharmaceutical giant Eli Lilly is reconsidering its major UK Gateway Lab investment. Learn why the company’s future plans in Britain are now uncertain.
UK economy
Read More
UK drugs sector hit by Merck’s scrapped £1bn expansion
A major blow for the uk drugs sector as pharmaceutical giant Merck cancels its planned £1bn research and manufacturing hub expansion in London, citing uncertainty.
UK Investment: 5 Takeaways from the ABPI Report
A new ABPI report highlights a worrying lag in UK investment for life sciences, calling for urgent policy changes to secure the nation’s economic future.
£1b project cancelled: Merck scraps all UK R&D ops
Pharmaceutical giant Merck has cancelled its flagship £1b project and is ceasing all R&D operations in the UK, a major blow to the nation’s science sector.